These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 792359)
1. Comparative effectiveness of combinations of amikacin with penicillin G and amikacin with carbenicillin in gram-negative septicemia: double-blind clinical trial. Klastersky J; Hensgens C; Meunier-Carpentier F J Infect Dis; 1976 Nov; 134 SUPPL():S433-40. PubMed ID: 792359 [TBL] [Abstract][Full Text] [Related]
2. Significance of antimicrobial synergism for the outcome of gram negative sepsis. Klastersky J; Meunier-Carpentier F; Prevost JM Am J Med Sci; 1977; 273(2):157-67. PubMed ID: 324279 [TBL] [Abstract][Full Text] [Related]
4. Comparative efficacy of ceftazidime vs. carbenicillin and amikacin for treatment of neonatal septicemia. Odio CM; Umana MA; Saenz A; Salas JL; McCracken GH Pediatr Infect Dis J; 1987 Apr; 6(4):371-7. PubMed ID: 3295738 [TBL] [Abstract][Full Text] [Related]
5. Amikacin therapy of infections in neutropenic patients. Valdivieso M; Feld R; Rodriguez V; Bodey GP Am J Med Sci; 1975; 270(3):453-63. PubMed ID: 1108649 [TBL] [Abstract][Full Text] [Related]
6. Amikacin therapy for severe gram-negative sepsis. Emphasis on infections with gentamicin-resistant organisms. Tally FP; Louie TJ; Weinstein WM; Bartlett JG; Gorbach SL Ann Intern Med; 1975 Oct; 83(4):484-8. PubMed ID: 1101761 [TBL] [Abstract][Full Text] [Related]
7. Preliminary clinical trial with amikacin in chronic recurrent gram-negative bacterial infections refractory to other antimicrobial agents. Dámaso D; Moreno-López M; Martínez-Beltrán J; García-Iglesias MC J Infect Dis; 1976 Nov; 134 SUPPL():S381-3. PubMed ID: 993631 [TBL] [Abstract][Full Text] [Related]
9. A randomized comparative trial of three aminoglycosides--comparison of continuous infusions of gentamicin, amikacin and sisomicin combined with carbenicillin in the treatment of infections in neutropenic patients with malignancies. Keating MJ; Bodey GP; Valdivieso M; Rodriguez V Medicine (Baltimore); 1979 Mar; 58(2):159-70. PubMed ID: 431401 [TBL] [Abstract][Full Text] [Related]
10. Piperacillin plus amikacin therapy v carbenicillin plus amikacin therapy in febrile, granulocytopenic patients. Winston DJ; Ho WG; Young LS; Hewitt WL; Gale RP Arch Intern Med; 1982 Sep; 142(9):1663-7. PubMed ID: 6214228 [TBL] [Abstract][Full Text] [Related]
11. [A case of E. coli septicemia successfully treated with amikacin (author's transl)]. Ueda Y; Matsumoto F; Saito A; Saigusa M Jpn J Antibiot; 1975 Oct; 28(5):655-6. PubMed ID: 1100873 [No Abstract] [Full Text] [Related]
12. Combination of amikacin and carbenicillin with or without cefazolin as empirical treatment of febrile neutropenic patients. The International Antimicrobial Therapy Project Group of the European Organization for Research and Treatment of Cancer. J Clin Oncol; 1983 Oct; 1(10):597-603. PubMed ID: 6366126 [TBL] [Abstract][Full Text] [Related]
13. Amikacin for treatment of infections in patients with malignant diseases. Bodey GP; Rodriguez V; Valdivieso M; Feld R J Infect Dis; 1976 Nov; 134 SUPPL():S421-7. PubMed ID: 993633 [TBL] [Abstract][Full Text] [Related]
14. Cefotaxime plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with hematologic malignancies. Martino P; Venditti M; Petti MC; Mandelli F; Serra P Infection; 1985; 13(3):125-9. PubMed ID: 3928495 [TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail. Lau WK; Young LS; Black RE; Winston DJ; Linne SR; Weinstein RJ; Hewitt WL Am J Med; 1977 Jun; 62(6):959-66. PubMed ID: 586099 [No Abstract] [Full Text] [Related]
16. In vitro models for the study of combination antibiotic therapy in neutropenic patients. Zinner SH; Dudley M; Blaser J Am J Med; 1986 Jun; 80(6B):156-60. PubMed ID: 3728526 [TBL] [Abstract][Full Text] [Related]
17. Use of Amikacin in a hospital for children: microbiological and clinical studies. Marget W; Reindke B; Versmold H J Infect Dis; 1976 Nov; 134 SUPPL():S412-9. PubMed ID: 825592 [TBL] [Abstract][Full Text] [Related]
18. Serum bactericidal activity as a therapeutic guide in severely granulocytopenic patients with gram-negative septicemia. Martino P; Venditti M; Valente B; Mandelli F; Serra P Eur J Cancer Clin Oncol; 1985 Apr; 21(4):439-45. PubMed ID: 3891360 [TBL] [Abstract][Full Text] [Related]
19. A double beta-lactam combination versus an aminoglycoside-containing regimen as empiric antibiotic therapy for febrile granulocytopenic cancer patients. De Jongh CA; Joshi JH; Thompson BW; Newman KA; Finley RS; Moody MR; Salvatore PC; Tenney JH; Drusano GL; Schimpff SC Am J Med; 1986 May; 80(5C):101-11. PubMed ID: 3521269 [TBL] [Abstract][Full Text] [Related]
20. Clinical evaluation of amikacin in treatment of infections due to gram-negative aerobic bacilli. Mathias RG; Ronald AR; Gurwith MJ; McCullough DW; Stiver HG; Berger J; Cates CY; Fox LM; Lank BA J Infect Dis; 1976 Nov; 134 SUPPL():S394-401. PubMed ID: 825590 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]